-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

626.O2.6 626. Aggressive Lymphomas Prospective Therapeutic Trials: Challenging Populations Clinically Relevant Abstract

Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
Clinical Trials, Lymphomas, Workforce, Diversity, Equity, Inclusion, and Accessibility (DEI/DEIA) , Diseases, Therapies, aggressive lymphoma, Lymphoid Malignancies, Study Population
Saturday, December 11, 2021: 4:00 PM-5:30 PM
B401-B402, Level 4, Building B (Georgia World Congress Center)
Moderators:
Jennifer Crombie, MD, Dana Farber Cancer Institute and Nilanjan Ghosh, MD, PhD, Levine Cancer Institute
Disclosures:
Ghosh: Incyte: Consultancy, Honoraria; AstraZeneca: Consultancy, Honoraria, Speakers Bureau; Genmab: Consultancy, Honoraria; Genentech: Research Funding; Gilead: Consultancy, Honoraria, Research Funding, Speakers Bureau; Pharmacyclics LLC, an AbbVie Company: Consultancy, Honoraria, Research Funding, Speakers Bureau; TG Therapeutics: Consultancy, Honoraria, Research Funding; Seattle Genetics: Consultancy, Honoraria, Speakers Bureau; ADC Therapeutics: Consultancy, Honoraria; Bristol Myers Squibb: Consultancy, Honoraria, Research Funding, Speakers Bureau; Epizyme: Honoraria, Speakers Bureau; Adaptive Biotech: Consultancy, Honoraria; Janssen: Consultancy, Honoraria, Speakers Bureau; Karyopharma: Consultancy, Honoraria; AbbVie: Honoraria, Speakers Bureau.
4:00 PM

Susan Prockop, MD1, Kris Michael Mahadeo, MD2, Amer Beitinjaneh, MD, MPH, MSc3*, Sylvain Choquet4*, Patrick Stiff, MD5, Ran Reshef, MD6*, Gowri Satyanarayana, MD7*, Saurabh Dahiya, MD8, Hema Parmar, PhD9*, Wei Ye, PhD9*, Laurence Gamelin, MD, PhD10* and Rajani Dinavahi, MD10

1Stem Cell Transplantation and Cellular Therapies, MSK Kids, Memorial Sloan Kettering Cancer Center, New York, NY
2MD Anderson Cancer Center, Mansfield, OH
3University of Miami /Jackson Memorial Hospital, Miami, FL
4Sorbonne Université, Hôpital de la Pitié-Salpêtrière, Paris, France
5Loyola University Medical Center, Chicago, IL
6Columbia University Medical Center, New York, NY
7Ingram Cancer Center, Vanderbilt Health, Nashville, TN
8University of Maryland School of Medicine, Baltimore, MD
9Atara Biotherapeutics, South San Francisco, CA
10Atara Biotherapeutics, Thousand Oaks, CA

4:15 PM

Bijal D. Shah, MD1, Caron Jacobson, MD2, Scott R. Solomon, MD3,4, Nitin Jain, MD5, Mark C. Johnson, PhD6*, Monika Vainorius, MD6*, Lou Yu, PhD7*, Christopher R. Heery, MD6, Alan F. List, MD6, Fiona He, MD8,9, Ran Reshef, MD, MSc10, Luke P. Akard, MD11, Craig S. Sauter, MD12, Adam J. Olszewski, MD13, Abhinav Deol14 and Koen Van Besien, MD, PhD15

1Department of Malignant Hematology, Moffitt Cancer Center, Tampa, FL
2Harvard Medical School, Dana-Farber Cancer Institute, Boston, MA
3Blood and Marrow Transplant Program, BMT Group of Georgia, Atlanta, GA
4Transplant and Cellular Immunotherapy Program, Northside Hospital Cancer Institute, Atlanta, GA
5Department of Leukemia, MD Anderson Cancer Center, Houston, TX
6Precision BioSciences, Inc., Durham, NC
7Clinical Operations, Precision BioSciences, Inc., Durham, NC
8University of Minnesota, Minneapolis, MN
9Division of Hematology Oncology and Transplantation, Department of Medicine, University of Minnesota, MINNEAPOLIS, MN
10Columbia Center for Translational Immunology, Columbia University, New York, NY
11Indiana Blood and Marrow Transplantation (IBMT), Indianapolis, IN
12Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
13Division of Hematology/Oncology, Brown University, Providence, RI
14Karmanos Cancer Institute, Wayne State University, Detroit, MI
15Presbyterian/Weill Cornell Medical College, New York, NY

4:30 PM

Makoto Yoshimitsu, MD1, Koji Izutsu, MD, PhD2, Shinichi Makita, MD, PhD, FACP2*, Kisato Nosaka, MD, PhD3, Atae Utsunomiya, MD4, Shigeru Kusumoto, MD5, Satoko Morishima, MD, PhD6*, Kunihiro Tsukasaki, MD, PhD7, Toyotaka Kawamata, MD, PhD8*, Takaaki Ono, MD, PhD9*, Shinya Rai, MD, PhD10*, Hiroo Katsuya, MD11*, Jun Ishikawa, MD, PhD12*, Hironori Yamada, MSc13*, Kazunobu Kato, MD, PhD14*, Masaya Tachibana, PhD13*, Yasuyuki Kakurai, PhD13*, Nobuaki Adachi, PhD13*, Kensei Tobinai, MD2, Kentaro Yonekura, MD, PhD4* and Kenji Ishitsuka, MD, PhD15

1Department of Hematology and Rheumatology, Kagoshima University Hospital, Kagoshima, Japan
2National Cancer Center Hospital, Tokyo, Japan
3Kumamoto University Hospital, Kumamoto, Japan
4Imamura General Hospital, Kagoshima, Japan
5Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan
6University of the Ryukyus Hospital, Okinawa, Japan
7Saitama Medical University, International Medical Center, Saitama, Japan
8The Institute of Medical Science, The University of Tokyo, Minato-ku, Japan
9Divison of Hematology, Hamamatsu University School of Medicine, Hamamatsu, Shizuoka, Japan
10Kindai University Hospital, Osaka, Japan
11Saga University Hospital, Saga, Japan
12Osaka International Cancer Institute, Osaka, Japan
13Daiichi Sankyo Co, Ltd, Tokyo, Japan
14Daiichi Sankyo, Inc, Basking Ridge, NJ
15Kagoshima University Hospital, Kagoshima, Japan

4:45 PM

Emma Verner, MBBS1,2*, Amanda Johnston, MBBS, FRACP, FRCPA2,3, Nalini Pati, MBBS, FRACP, FRCPA, DCH, MD, DNB4,5*, Eliza Hawkes, MD6,7, Hui-Peng Lee, MBChB, FRACP, FRCPA, BHB8*, Tara Cochrane, MBBS, FRCPA, FRACP9,10, Chan-Yoon Cheah11,12, Robin J Filshie, MBChB, PhD, FRACP, FRCPA13, Duncan Purtill14,15*, Hanlon Sia, MBBS, FRACP, FRCPA16*, Anoop Kumar Enjeti, MBBS, FRCPA, FRACP, PhD, MD, MRCP17,18, Christina Brown, MBBS PhD FRACP FRCPA2,19, Nicholas E. Murphy, FRCPA, MBBS, FRACP20,21, Jennifer Curnow, MBBS FRACP FRCPA PhD22,23*, Kenneth Lee, MBChB, FRCPA2,24*, Mannu Walia, Msc PhD25*, Belinda Butcher, BSci, MBiostat, PHD26,27* and Judith Trotman, FRACP2,28

1Department of Haematology, Concord Repatriation General Hospital, Concord, NSW, Australia
2University of Sydney, Sydney, NSW, Australia
3Westmead Hospital, Westmead, NSW, Australia
4ANU Medical School, Canberra, Australia
5The Canberra Hospital, Canberra, Australia
6Department of Medical Oncology and Haematology, Olivia Newton John Cancer Research and Wellness Centre, Heidelberg, AUS
7Eastern Health, Box Hill, VIC, Australia
8Flinders Medical Centre, Adelaide, Australia
9Griffiths University, Gold Coast, Australia
10Department of Haematology, Gold Coast University Hospital, Southport, Australia
11Department of Haematology, Sir Charles Gairdner Hospital, Nedlands, WA, Australia
12University of Western Australia, Crawley, WA, Australia
13Department of Hematology, St. Vincent's Hospital Melbourne, Melbourne, VIC, Australia
14University of Western Australia, Perth, Australia
15Department of Haematology, Fiona Stanley Hospital, Perth, Australia
16The Tweed Hospital, 4515, AUS
17University of Newcastle, Newcastle, Australia
18Calvary Mater Hospital, Waratah, AUS
19Institute of Haematology, Royal Prince Alfred Hospital, Sydney, Australia
20University of Tasmania, Hobart, Australia
21Royal Hobart Hospital, Hobart, Australia
22Department of Haematology, Westmead Hospital, Western Sydney Local Health District, Sydney, Australia
23Faculty of Health and Medicine, University of Sydney, Sydney, NSW, Australia
24Anatomical Pathology, NSW Health Pathology, Concord Repatriation General Hospital, Concord, Australia
25Australasian Leukaemia and Lymphoma Group, Richmond, Australia
26WriteSource Medical Pty Ltd, Lane Cove, Australia
27University of New South Wales, Sydney, Australia
28Department of Haematology, Concord Hospital, Concord, NSW, Australia

5:00 PM

Guido Gini1*, Monica Tani, MD2*, Renato Bassan, MD3*, Alessandra Tucci, MD4*, Filippo Ballerini5*, Michela Sampaolo6*, Francesco Merli, MD7*, Francesca Re8*, Attilio Olivieri, MD9, Mauro Petrini10*, Ombretta Annibali, MD, PhD11*, Anna Marina Liberati12*, Carlo Visco, MD13*, Annalisa Arcari14*, Sergio Storti, MD15, Alberto Fabbri, MD16*, Gerardo Musuraca17*, Vittorio Ruggero Zilioli, MD18*, M. Christina Cox, MD, PhD19 and Stefano Luminari20

1Hematology Clinic, AOU Ospedali Riuniti di Ancona, Ancona, Italy
2Hematology Unit, Ospedale Santa Maria delle Croci, Ravenna, Italy
3Ospedale dell'Angelo e SS. Giovanni e Paolo, Venezia Mestre, Italy
4Hematology, Department of Hematology, ASST Spedali Civili, Brescia, Italy
5IRCCS Ospedale Policlinico San Martino, Clinic of Hematology, Department of Internal Medicine (DiMI), Genova, Italy
6Hematology Clinic, A.O.U. Ospedali Riuniti, Ancona, Italy
7Hematology, AUSL-IRCCS, Reggio Emilia, Italy
8Division of Hematology, Azienda Ospedaliero-Universitaria di Parma, Parma, Italy
9Ospedali Riuniti di Ancona, Clinic of Hematology, Ancona, Italy
10AOU Ospedali Riuniti di Ancona, Ancona, Italy
11Unit of Hematology, Stem Cell Transplantation, University Campus Bio Medico, Rome, Italy
12S.C. Oncoematologia, Università degli Studi di Perugia, A.O. Santa Maria, Terni, Italy
13Department of Medicine, Section of Hematology, University of Verona, Verona, Italy
1421Hematology Un it, Ospedale Guglielmo da Saliceto, Piacenza, Italy
15Oncoematologia, Fondazione di Ricerca e Cura Giovanni Paolo II, Campobasso, ITA
16Unit of Hematology, Azienda Ospedaliera Universitaria Senese, Siena, Italy
17Hematology Unit, IRCCS - Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (I.R.S.T.), Meldola (FC), Italy
18Division of Hematology, ASST Grande Ospedale Metropolitano Niguarda, Milano, IT-MI, Italy
19Hematology, Sant'Andrea Hospital, Rome, Italy
20University of Modena and Reggio Emilia, Hematology, Arcispedale Santa Maria Nuova IRCCS, Reggio Emilia, Italy

5:15 PM

Pier Luigi Zinzani, MD1, Catherine Thieblemont, MD, PhD2, Vladimir Melnichenko3*, Krimo Bouabdallah4*, Jan Waleswski5*, Alejandro Majlis6, Laura Fogliatto7, Alejandro Martin Garcia-Sancho8*, Beth Christian9, Zafer Gulbas10*, Muhit Özcan11, Guilherme Fleury Perini, MD12, Gilles Salles, MD, PhD13, Margaret A. Shipp, MD14, Seth Thompson15*, Samhita Chakraborty15*, Patricia Marinello15* and Philippe Armand16

1IRCCS Azienda Ospedaliero-Universitaria di Bologna Istituto di Ematologia “Seràgnoli” and Dipartimento di Medicina Specialistica, Diagnostica e Sperimentale Università di Bologna, Bologna, Italy
2Hemato-Oncology Department, APHP, Saint-Louis Hospital, Paris, France
3Pirogov National Medical Surgical Center, Moscow, Russian Federation
4Department of Hematology and Cell Therapy, University Hospital, Bordeaux, France
5Maria Sklodowska-Curie National Research Institute of Oncology, European Reference Network, Warszawa, Poland
6Clinica Alemana de Santiago, Vitacura, Chile
7Hospital de Clinicas de Porto Alegre, Porto Alegre, Brazil
8Hematology Department, Hospital Universitario de Salamanca, IBSAL, CIBERONC, Salamanca, Spain
9The James Cancer Hospital and Solove Research Institute, The Ohio State University, Columbus, OH
10Anadolu Medical Center, Gebze, Turkey
11Department of Hematology and Bone Marrow Transplantation Unit, Ankara University Faculty of Medicine, Ankara, Turkey
12Hospital Israelita Albert Einstein, São Paulo, AC, Brazil
13Hématologie, Hospices Civils de Lyon and Université de Lyon, Lyon, France
14Dana-Farber Cancer Institute, Boston, MA
15Merck & Co., Inc., Kenilworth, NJ
16Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA

*signifies non-member of ASH